Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 15:49:05 2026-06-29 EDT			5-day change	1st Jan Change
23.89 ^USD	+7.18%		+26.46%	+50.57%

12:28pm	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index	CI
11:34am	Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell 2000 Value Benchmark	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility	Consensus
MONTE ROSA THERAPEUTICS, INC.	1.88B	-	B	-	-
LONZA GROUP AG	46.2B		AAA
REVOLUTION MEDICINES, INC.	38.71B	-	B	-	-
IQVIA HOLDINGS INC.	31.9B		AAA
BEONE MEDICINES AG	31.12B		-
CELLTRION, INC.	23.77B		A
ASCENDIS PHARMA A/S	16.2B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.05B		BBB
EUROFINS SCIENTIFIC SE	13.74B		AA
IONIS PHARMACEUTICALS, INC.	13.42B	-	A	-	-
ICON PUBLIC LIMITED COMPANY	13.01B		AAA
BIO-TECHNE CORPORATION	11.06B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.39B		AA
TEMPUS AI, INC.	10.08B		A		-
APOGEE THERAPEUTICS, INC.	9.93B	-	B	-	-
ALKERMES PLC	9.18B		A
PRAXIS PRECISION MEDICINES, INC.	9.14B	-	B	-	-
KYMERA THERAPEUTICS, INC.	8.89B	-	BBB	-	-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-	-	-	-
QIAGEN N.V.	8.15B		AAA
Average	16.51B		A
Weighted average by Cap.			A